These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12423618)

  • 21. Enrofloxacin treatment of long-tailed macaques with acute bacillary dysentery due to multiresistant Shigella flexneri IV.
    Line AS; Paul-Murphy J; Aucoin DP; Hirsh DC
    Lab Anim Sci; 1992 Jun; 42(3):240-4. PubMed ID: 1320152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shigella bacteremia: a retrospective study.
    Greenberg D; Marcu S; Melamed R; Lifshitz M
    Clin Pediatr (Phila); 2003 Jun; 42(5):411-5. PubMed ID: 12862343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International note. Antibiotics in the management of shigellosis.
    Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
    [No Abstract]   [Full Text] [Related]  

  • 24. Shigella flexneri bacteraemia in a patient with acquired immune deficiency syndrome.
    Glupczynski Y; Hansen W; Jonas C; Deltenre M
    Acta Clin Belg; 1985; 40(6):388-90. PubMed ID: 3913261
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unusual case of diarrhea.
    Monaghan J
    Nephrol Nurs J; 2005; 32(4):433-4. PubMed ID: 16180784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.
    Thompson CN; Thieu NT; Vinh PV; Duc AN; Wolbers M; Vinh H; Campbell JI; Ngoc DT; Hoang NV; Thanh TH; The HC; Nguyen TN; Lan NP; Parry CM; Chau NV; Thwaites G; Thanh DP; Baker S
    J Antimicrob Chemother; 2016 Mar; 71(3):807-15. PubMed ID: 26679253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymicrobial and recurrent bacteremia with Shigella in a patient with AIDS.
    Kristjánsson M; Viner B; Maslow JN
    Scand J Infect Dis; 1994; 26(4):411-6. PubMed ID: 7984973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple drug-resistance in Shigella flexneri isolated from a patient with human immunodeficiency virus.
    Gander RM; LaRocco MT
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):193-6. PubMed ID: 3326711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is whole genome sequencing the answer for identifying
    Amos D; Khanna P; Aali SA; Rao GG
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31811109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shigella and shigellaemia.
    De Mol P; Brasseur D; Schatteman E; Kassam S
    Scand J Infect Dis; 1981; 13(1):75-7. PubMed ID: 7017908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production.
    Dhital S; Sherchand JB; Pokharel BM; Parajuli K; Mishra SK; Sharma S; Kattel HP; Khadka S; Khatiwada S; Rijal B
    BMC Res Notes; 2017 Jun; 10(1):192. PubMed ID: 28583187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015.
    Gaudreau C; Pilon PA; Cornut G; Marchand-Senecal X; Bekal S
    Emerg Infect Dis; 2016 Nov; 22(11):2016-2018. PubMed ID: 27767915
    [No Abstract]   [Full Text] [Related]  

  • 34. [Shigella flexneri diarrhoea with positive blood culture].
    Taieb B; Ghnassia JC; Berche P; Hennequet A
    Ann Pediatr (Paris); 1978; 25(5-6):266-8. PubMed ID: 16114334
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of Flexner's dysentery with ofloxacin].
    Rakhmanova AG; Kulikov VP
    Antibiot Khimioter; 1996; 41(9):95. PubMed ID: 9005798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the degree of sensitivity to antibiotics of Shigella isolated from patients with dysentery in a city infectious disease hospital over the past 8 years].
    Givental' NI; Saparov OS; Bogdanova LF; Chekrygina ON; Vel'mina EA
    Antibiot Khimioter; 1988 Feb; 33(2):135-7. PubMed ID: 3288150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience in the treatment of dysentery].
    Ribiczey P; Beke G
    Orv Hetil; 1974 Mar; 115(12):677-9. PubMed ID: 4361059
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
    Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group
    Pediatr Infect Dis J; 2002 Dec; 21(12):1136-41. PubMed ID: 12488664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shigella Bacteremia, Georgia, USA, 2002-2012
    Tobin-D'Angelo M; Oosmanally N; Wilson SN; Anderson EJ; Segler S; Poventud L
    Emerg Infect Dis; 2020 Jan; 26(1):122-124. PubMed ID: 31855540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.